Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD withdrawal after prolonged dosing in healthy adults
NL-OMON42668Active, not recruiting
- Sponsor
- PRA Health Sciences
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in epilepsy comparing GWP42003-P with Placebo (2 arms). Primary endpoints: Withdrawal symptoms by Cannabis Withdrawal Scale and Withdrawal symptoms by Penn Physician Withdrawal Checklist. Started Nov 2015; status: active, not recruiting.
02
Drugs
cannabidiol
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON42668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42668.